Document is current
Any future updates will be listed below
-
Authors
Kim, Jeayoun
Lee, Seungwon
Jeong, Ji Seon
Ahn, Hyun Joo
Lee, Sang Hyun
Jo, Sungwoo
Kim, Wontae
Lee, Suk Young
-
Funding
Funding for this research was provided by:
Hana Pharm Co., Ltd., Seoul, Korea (PHO021605)
- License Information
-
More Information
Article History
Received: 18 July 2025
Accepted: 23 October 2025
First Online: 25 November 2025
Declarations
:
: This study was supported by Hana Pharm Co., Ltd., the distributor of remimazolam in South Korea. The sponsor had no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript. The authors declare no other competing interests.
